Anti-IL-18 antibodies and their uses
US9255144B2 · kind B2 · utility
5Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2011 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Dec 20, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides human, humanized and/or chimeric antibodies as well as fragments, derivatives/conjugates and compositions thereof with a specific binding affinity for interleukin-18. The invention includes the use of these antibodies for diagnosing and treating diseases associated with increased IL-18 activity, the latter in the form of a pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.